Form 8-K - Current report:
SEC Accession No. 0001104659-19-016808
Filing Date
2019-03-22
Accepted
2019-03-22 16:02:28
Documents
3
Period of Report
2019-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7005_18k.htm 8-K 22602
2 EX-99.1 a19-7005_1ex99d1.htm EX-99.1 110461
3 GRAPHIC g70051mmi001.jpg GRAPHIC 3139
  Complete submission text file 0001104659-19-016808.txt   138659
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 19699818
SIC: 2834 Pharmaceutical Preparations